Wei Xue

Circulating tumor DNA and tissue complementarily detect genomic alterations in metastatic hormone-sensitive prostate cancer

Ruiliang Wang, Guanjie Yang, Jun Xie, 2024, iScience.

ADORA2A-driven proline synthesis triggers epigenetic reprogramming in neuroendocrine prostate and lung cancers

Pengfei Ma, G. Zhuang, B. Dong, 2023, The Journal of clinical investigation.

Integrative proteogenomic profiling of high-risk prostate cancer samples from Chinese patients indicates metabolic vulnerabilities and diagnostic biomarkers.

Minjia Tan, Yanqing Wang, B. Dong, 2024, Nature cancer.